By Devika Patel
Knoxville, Tenn., Aug. 4 - Oncothyreon Inc. said it has arranged a $15 million registered direct offering of stock.
The company will sell approximately 2.28 million common shares at $6.5775 per share, along with warrants for approximately 684,000 shares. The shares and warrants are being sold in units of one common share and 0.3 of a warrant.
The warrants are exercisable at $6.5775 for two years.
Rodman & Renshaw, LLC is the agent.
Settlement is expected Aug. 7.
Oncothyreon is an Edmonton, Alta., biotechnology company.
| Issuer: | Oncothyreon Inc.
|
| Issue: | Units of one share and 0.3 of a warrant
|
| Amount: | $15 million
|
| Shares: | 2.28 million (approximate)
|
| Price: | $6.5775
|
| Warrants: | For approximately 684,000 shares
|
| Warrant expiration: | Two years
|
| Warrant strike price: | $6.5775
|
| Agent: | Rodman & Renshaw, LLC
|
| Pricing date: | Aug. 4
|
| Settlement date: | Aug. 7
|
| Stock symbol: | Nasdaq: ONTY
|
| Stock price: | $6.56 at close Aug. 3
|
| Market capitalization: | $118 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
